Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein deglycase DJ-1 is a highly conserved, multifunctional enzyme belonging to the Class I glutamine amidotransferase-like superfamily, and is found in many mammalian tissues including the brain. DJ-1 acts as a redox-sensitive chaperone and deglycase, repairing protein and nucleic acids damaged by metabolic byproducts like methylglyoxal and glyoxal, particularly under oxidative stress. It inhibits α-synuclein aggregation, plays important roles in protection against neurodegeneration and in cellular redox signaling, and regulates androgen receptor-dependent transcription. Mutations in the PARK7 gene encoding DJ-1 cause autosomal recessive, early-onset Parkinson's disease, making DJ-1 a key disease-associated protein and a focus of drug discovery for neuroprotective therapies. DJ-1 additionally serves as a biomarker for Parkinson's disease and potentially certain cancers, but its broad cellular functions and tight regulation necessitate careful consideration when developing therapeutic interventions.
Drugs targeting DJ-1 may act by enhancing its antioxidative activity, stabilizing its structure, augmenting deglycase function, or reducing its pathological oxidation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein deglycase DJ-1 (DJ-1).